Pan‐cyclin‐dependent kinase inhibition is a potential treatment for adenoid cystic carcinoma that downregulates the MYB::NFIB fusion and induces tumor regression
Year: 2025
Type: article
Source: 癌症:英文版
DOI: 10.1002/cac2.70079
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,080
OpenAlex ID: W4416168940
